
About Element Biosciences
Element Biosciences is a Healthcare company based in San Diego (United States) founded in 2017 by Michael Previte and Molly He. Benchtop DNA sequencers are developed for research and diagnostic uses. Element Biosciences has raised $853.3 million across 8 funding rounds from investors including Fidelity Investments, Morgan Stanley and Samsung. The company has 447 employees. Element Biosciences has completed 1 acquisition, including Element Biosciences. Element Biosciences was last valued at $1 billion in February 2026. Its chief executive, as recorded, is Molly He. Its website elementbiosciences.com draws about 39 thousand monthly visits. Element Biosciences offers products and services including AVITI24, Cloudbreak Sequencing Kits, Trinity Sequencing Kits, and ElemBio Cloud. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Genomics. Its competitors include 10X Genomics, xMD and Plexigen; 2 of its 3 listed competitors have raised funding.
Company details
Founded in 2017 and based in San Diego, United States, operations are centered in the biotechnology sector with a focus on genomics. Benchtop DNA sequencing technology is provided through the AVITI sequencer, which achieves high data quality via an enhanced contrast-to-noise ratio. Applications are targeted at research and diagnostic markets, supporting advancements in genetic analysis.
- Headquarters San Diego, United States
- Employees 447
- Founders Michael Previte, Molly He
- Stage Unicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website elementbiosciences.com
- Social LinkedIn X Facebook YouTube
- Total Equity Funding$853.3M (USD)
in 8 rounds
- Latest Funding Round$175M (USD), Series E
Jun 2026
- InvestorsFidelity Investments
& 13 more
- Employee Count447
- Investments & Acquisitions
Products & Services of Element Biosciences
Element Biosciences offers a comprehensive portfolio of products and services, including AVITI24, Cloudbreak Sequencing Kits, Trinity Sequencing Kits, and ElemBio Cloud.
Instrument for spatial co-detection of RNA, protein, and morphology in sequencing.
Kits for DNA and RNA sequencing applications in research.
Kits that simplify targeted sequencing workflows.
Software platform for managing sequencing data and analysis.
Apps and channels of Element Biosciences
its YouTube channel Element Biosciences has 482 subscribers and 30 videos.
Videos from Element Biosciences
The most watched videos on Element Biosciences's YouTube channel, Element Biosciences (482 subscribers). Click a video to play it here.
More on Element Biosciences.
Funding Insights of Element Biosciences
Element Biosciences has successfully raised a total of $853.3M across 8 strategic funding rounds. The most recent funding activity was a Series E round of $175 million completed in June 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $853.3M
- Total Rounds 8
- Last Round Series E — $175M
- First Round $224,881
(Sep 2017)
- Investors Count 14
All 8 funding rounds of Element Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2026 | $175M | Series E | – | – | |
| Jul 2024 | $277M | Series D | – | Wellington | |
| Jun 2021 | $276M | Series C | – | Janus Henderson Investors, Logos | |
| Jun 2020 | $30M | Series B | – | – | – |
| Jan 2020 | $80.3M | Series B | – | Fidelity Investments, JSCapital | |
| Jun 2019 | $15M | Series A | – | Foresite Capital, Venrock | – |
| Feb 2018 | $221,507 | Grant | – | – | |
| Sep 2017 | $224,881 | Grant | – | – |
| Date | Valuation | Stage |
|---|
Full valuation and stage history of Element Biosciences
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $1B (Feb 2026). 14 investors in total: 14 institutional.
Investors in Element Biosciences
Element Biosciences has secured backing from 14 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, Morgan Stanley and Samsung.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Multi-stage investment firm invests in healthcare and life sciences companies | foresitecapital.com | New York, United States | ||
Multiple sectors are targeted for venture capital investments. | 1934 | janushenderson.com | London, United Kingdom | |
Private equity fund focused on the biotechnology sector | logoscapital.com | San Francisco, United States | ||
Private equity investments are directed toward US-based companies. | meritechcapital.com | Palo Alto, United States | ||
Venture capital firm focused on tech sectors | venrock.com | Palo Alto, United States | ||
Investment in early-stage startups focusing on healthcare, AI, and industrial technology. | fusionfund.com | |||
Diversified investment management services are provided to institutional clients. | wellington.com | Boston, United States | ||
Multi-category electronic products are manufactured globally by the company. | 1969 | samsung.com | Suwon-si, South Korea | |
Provider of brokerage accounts, retirement planning, wealth management, and trading platforms | 1946 | fidelity.com | Boston, United States | |
Diversified asset management services are provided to investors globally. | 1937 | troweprice.com | Baltimore, United States |
Investor details for Element Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Element Biosciences
137 people are tracked at Element Biosciences (46 in leadership, 2 in board & advisors, 89 in team); the tracked headcount is 447.
| Name | Role | Group |
|---|---|---|
Michael Previte | Co-Founder & CTO | Leadership |
Molly He | Co-Founder & CEO | Leadership |
Andrew Price | Vice President Systems Integration | Leadership |
Shawn Levy | Chief Scientific Officer & SVP, Applications | Leadership |
Brian Stolz | Chief People Officer | Leadership |
Amirali Kia | Vp, Artificial Intelligence And Data Science | Leadership |
Kim Morch | Associate Director Of Program Management | Leadership |
Kristina Wheeler | Director, Accounting | Leadership |
Holly Barnes | Sr. Director Commercial Operations | Leadership |
Danae van Oene | Senior Vice President, Global Sales And Support | Leadership |
Adeline M. | Director, Surface Chemistry | Leadership |
Semyon Kruglyak | VP Of Informatics | Leadership |
Claudia J. | Vp, Software | Leadership |
Matthew Byrne | Director, Quality And Regulatory | Leadership |
Ryan Lown | Sr. Director, Finance | Leadership |
John Dimalanta | Sr. Director Of Global Service & Support | Leadership |
Fangfang Hu | Director, Marketing And Business Development | Leadership |
Howard Z. | Head Of Business Development | Leadership |
Evie Felton | Sr. Director, Commercial Marketing | Leadership |
Sunny Kim | Director Strategic Sourcing | Leadership |
117 more people are available in the full profile.
Complete people profiles for Element Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Element Biosciences
Element Biosciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Element Biosciences.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
DNA sequencing technologies are developed for microbiome and genomic applications. | loopgenomics.com | Sunnyvale, United States | 2015 | Feb 2022 | •••• |
Complete acquisition details for Element Biosciences
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Element Biosciences
5 dated milestones of Element Biosciences across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Element Biosciences is founded.
- Funding First funding round of $225K.
- Acquisition Acquires Element Biosciences.
- Milestone Reaches Unicorn status.
- Funding Latest funding round, Series E, of $175.0M.
Competitors of Element Biosciences
Element Biosciences has 3 listed competitors in our database, 2 of them funded. They include 10X Genomics, xMD and Plexigen.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| 10xgenomics.com | 2012 | Pleasanton, United States | $199.9M | 961 | Instrument systems for genomic research and sequencing libraries are developed. | |
| xmddiagnostics.com | 2015 | Baltimore, United States | $775,000 | Laboratory instruments and consumables are developed for life science research. | ||
| plexigen.com | 1999 | Cary, United States | Offers tools and services for genomics and proteomic testing. |
Detailed competitors of Element Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Element Biosciences
The website of Element Biosciences (elementbiosciences.com) receives about 39.1K visits a month.
- Monthly visits39.1K
Websites whose visitors overlap most with Element Biosciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
careers.mrcooper.com | careers.mrcooper.com | 100% | #674,473 | – | |
careers.racetrac.com | careers.racetrac.com | 97% | #323,228 | – | |
climatetechlist.com | climatetechlist.com | 95% | #437,407 | – | |
careers.aspendental.com | careers.aspendental.com | 94% | #338,059 | – | |
| oysterlink.com | 93% | 190K | #299,386 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Element Biosciences
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Element Biosciences (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Element Biosciences
Complete news archive for Element Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Element Biosciences
Element Biosciences was founded in 2017.
Element Biosciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Molly He is the CEO of Element Biosciences, as recorded in our data. They have also founded this company.
Element Biosciences is a funded company, having raised a total of $853.3M across 8 funding rounds to date. The company's 1st funding round was a Grant of $224.88K, raised on Sep 2017.
Element Biosciences has 447 employees.
Founded in 2017 and based in San Diego, United States, operations are centered in the biotechnology sector with a focus on genomics. Benchtop DNA sequencing technology is provided through the AVITI sequencer, which achieves high data quality via an enhanced contrast-to-noise ratio. Applications are targeted at research and diagnostic markets, supporting advancements in genetic analysis.
Element Biosciences's top competitors include 10X Genomics, xMD and Plexigen.
Element Biosciences offers AVITI24, Cloudbreak Sequencing Kits, Trinity Sequencing Kits, and ElemBio Cloud.
Element Biosciences has made 1 acquisition, including Element Biosciences.
Element Biosciences has 14 investors. Key investors include Fidelity Investments, Morgan Stanley, Samsung, T. Rowe Price, and HHS.
The valuation of Element Biosciences is $1B as of Feb 2026.
